ES8604256A1 - Un procedimiento para la preparacion de 9-deoxo-9a-metil-9a-aza-9a-homoeritromicina d o una sal de la misma - Google Patents

Un procedimiento para la preparacion de 9-deoxo-9a-metil-9a-aza-9a-homoeritromicina d o una sal de la misma

Info

Publication number
ES8604256A1
ES8604256A1 ES535625A ES535625A ES8604256A1 ES 8604256 A1 ES8604256 A1 ES 8604256A1 ES 535625 A ES535625 A ES 535625A ES 535625 A ES535625 A ES 535625A ES 8604256 A1 ES8604256 A1 ES 8604256A1
Authority
ES
Spain
Prior art keywords
azahomoerythromycin
derivative
intermediates therefor
aza
homoerythromycin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES535625A
Other languages
English (en)
Other versions
ES535625A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of ES8604256A1 publication Critical patent/ES8604256A1/es
Publication of ES535625A0 publication Critical patent/ES535625A0/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE 9-DEOXO-9A-METIL-9A-AZA-9A-HOMOERITROMICINA D O UNA SAL DE LA MISMA. CONSISTE EN HACER REACCIONAR 9-DEOXO-9A-AZA-9A-HOMOERITROMICINA D CON FORMALDEHIDO, EN PRESENCIA DE UN AGENTE REDUCTOR, COMO ACIDO FORMICO, ENTRE 20 Y 60JC, PARA OBTENER EL COMPUESTO 9-DEOXO-9A-METIL-9A-AZA-9A-HOMOERITROMICINA D, DE FORMULA (I) O SUS SALES FARMACEUTICAMENTE ACEPTABLES POR ADICION DE ACIDOS COMO: CLH, BRH, NO3H, SO4, H2, HOOC-CH2-COOH, CIS Y TRANS-HOOC-CH-CH-COOH, CH3SO3H, Y P-CH3C6H4SO3H. SIENDO: R, METILO; Y RA Y RB, HIDROGENO. SE UTILIZAN, ASI COMO LOS PRODUCTOS DE LA SINTESIS INTERMEDIOS, EN FARMACOLOGIA PARA EL TRATAMIENTO ORAL DE INFECCIONES BACTERIANAS SUSCEPTIBLES EN MAMIFEROS.
ES535625A 1983-09-06 1984-09-04 Un procedimiento para la preparacion de 9-deoxo-9a-metil-9a-aza-9a-homoeritromicina d o una sal de la misma Expired ES8604256A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/529,828 US4465674A (en) 1983-09-06 1983-09-06 Azahomoerythromycin D derivative and intermediates therefor

Publications (2)

Publication Number Publication Date
ES8604256A1 true ES8604256A1 (es) 1986-01-16
ES535625A0 ES535625A0 (es) 1986-01-16

Family

ID=24111406

Family Applications (1)

Application Number Title Priority Date Filing Date
ES535625A Expired ES8604256A1 (es) 1983-09-06 1984-09-04 Un procedimiento para la preparacion de 9-deoxo-9a-metil-9a-aza-9a-homoeritromicina d o una sal de la misma

Country Status (7)

Country Link
US (1) US4465674A (es)
EP (1) EP0136830A3 (es)
JP (1) JPS6072897A (es)
CA (1) CA1240320A (es)
DK (1) DK157877C (es)
ES (1) ES8604256A1 (es)
GR (1) GR80278B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4518590A (en) * 1984-04-13 1985-05-21 Pfizer Inc. 9α-Aza-9α-homoerythromycin compounds, pharmaceutical compositions and therapeutic method
MX13723A (es) * 1987-11-10 1993-05-01 Pfizer Procedimiento para preparar derivados de 9-desoxo-9a-alil- y propargil-9a-aza-9a-homoeritromicina a
US5075289A (en) * 1988-06-07 1991-12-24 Abbott Laboratories 9-r-azacyclic erythromycin antibiotics
US5912331A (en) * 1991-03-15 1999-06-15 Merck & Co., Inc. Process for the preparation of 9-deoxo-9(Z)-hydroxyiminoerythromycin A
US5985844A (en) * 1992-03-26 1999-11-16 Merck & Co., Inc. Homoerythromycin A derivatives modified at the 4"-and 8A-positions
US5189159A (en) * 1992-04-02 1993-02-23 Merck & Co., Inc. 8a-AZA-8a-homoerythromycin cyclic iminoethers
US5215980A (en) * 1992-01-17 1993-06-01 Merck & Co., Inc. 10-AZA-9-deoxo-11-deoxy-erythromycin A and derivatives thereof
US5210235A (en) * 1992-08-26 1993-05-11 Merck & Co., Inc. Methods of elaborating erythromycin fragments into amine-containing fragments of azalide antibiotics
US5332807A (en) * 1993-04-14 1994-07-26 Merck & Co., Inc. Process of producing 8A- and 9A-azalide antibiotics
ATE306491T1 (de) 2000-08-23 2005-10-15 Wockhardt Ltd Verfahren zur herstellung von wasserfreiem azithromycin
US20040067898A1 (en) * 2001-11-27 2004-04-08 John Somberg Synthesis and separation of optically active isomers of erythromycin and their biological actions
YU91603A (sh) 2001-05-22 2006-08-17 Pfizer Products Inc. Kristalni oblici azitromicina
US6861413B2 (en) * 2001-05-22 2005-03-01 Pfizer Inc. Stable non-dihydrate azithromycin oral suspensions
US20060116336A1 (en) * 2004-03-17 2006-06-01 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
US7468428B2 (en) * 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
JP4762648B2 (ja) * 2005-08-30 2011-08-31 三和シヤッター工業株式会社 窓装置のロック装置

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3736313A (en) * 1971-02-26 1973-05-29 Abbott Lab Erythromycin derivatives
YU43116B (en) * 1979-04-02 1989-04-30 Pliva Pharm & Chem Works Process for preparing 11-aza-4-o-cladinosyl-6-o-desosaminyl-15-ethyl-7,13,14-trihydroxy-3,5,7,9,12,14-hexamethyl-oxacyclopentadecane-2-one(11-aza-10-deox
YU43006B (en) * 1981-03-06 1989-02-28 Pliva Pharm & Chem Works Process for preparing n-methyl-11-aza-10-deoxo-10-dihydro erythromycin and derivatives thereof
US4496546A (en) * 1982-04-12 1985-01-29 Pfizer Inc. Erythromycin D and esters thereof
US4474768A (en) * 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
PH19293A (en) * 1982-11-15 1986-03-04 Pfizer Epimeric azahomoerythromycin,pharmaceutical composition containing the same and method of use thereof

Also Published As

Publication number Publication date
GR80278B (en) 1985-01-04
EP0136830A3 (en) 1986-03-19
DK157877C (da) 1990-07-23
JPS6072897A (ja) 1985-04-24
US4465674A (en) 1984-08-14
DK423184D0 (da) 1984-09-05
DK157877B (da) 1990-02-26
EP0136830A2 (en) 1985-04-10
CA1240320A (en) 1988-08-09
DK423184A (da) 1985-03-07
ES535625A0 (es) 1986-01-16

Similar Documents

Publication Publication Date Title
ES8604256A1 (es) Un procedimiento para la preparacion de 9-deoxo-9a-metil-9a-aza-9a-homoeritromicina d o una sal de la misma
ES8600327A1 (es) Un procedimiento para la preparacion de 4"-epi-9-desoxo-9a-metil-9a-aza-9a-homoeritromicina a
FR2662441B1 (fr) Procede de preparation enantioselective de derives de la phenylisoserine.
ATE71113T1 (de) Antibiotikum a 40926 mannosyl aglycon.
CA1266247C (en) ANTIBIOTIC PREPARED BY LYSOBACTER SP. SC14.067
SE8502135D0 (sv) 4'-deschlororebeccamycin and process for its preparation
AU571206B2 (en) 6-hydroxyalkyl-penem derivatives
ATE55991T1 (de) 2,6-substituierte pyridinverbindungen mit weiteren substituenten.
FI860426A (fi) Primycinkomponenter samt foerfarande foer avskiljning av antibiotkomplex.
ES8704964A1 (es) Un procedimiento para preparar derivados esteres del antibiotico l 17046.
ATE38519T1 (de) Azahomoerythromycin-b-derivate und zwischenprodukte.
DE3161185D1 (en) New antibiotic substance, its process of production and pharmaceutical composition containing the same
GB1388180A (en) Acetals
ATE18233T1 (de) De-(mycinosyloxy)-tylosin-derivate.
KR900006517A (ko) 항생제 pb-6042류
ATE42571T1 (de) Antibiotikum a 51568, faktoren a und b.
FI841240A0 (fi) Foerbaettringar i makrolidantibiotika.
ES8306388A1 (es) Procedimiento para preparar antibioticos y antitumorigenos de la familia de bleomicina-fleomicina, designados ll-b01208 y ll-b01208 y las sales de adicion de acido farmaceuticamente aceptables de los mismos.
GB1388460A (en) N-demethyl-celesticetin derivatives
YU147385A (en) Process for obtaining new antibiotics
SU1203863A1 (ru) 6-циклогексил-2-окса-6-азаспиро (3,3) гептан, подавляющий рост сульфатвосстанавливающих бактерий
DK348988D0 (da) Antibiotikum (fumifungin), mikrobiologisk fremgangsmaade til dets fremstilling samt dets anvendelse
SU1269465A1 (ru) Способ получения 2-анилино-7-гидрокси-6н-1,3,4-тиадиазепинов
SU946121A1 (ru) Система управления створками реверса тяги турбореактивного двигателя
SU1226790A1 (ru) Реагент для предотвращения роста сульфатвосстанавливающих бактерий

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970401